Med -4- You L L C Pharmacy Location: 3970 Peachtree Industrial Blvd, Berkeley Lake, Georgia 30096 Phone: (470) 299-5292 |
News Archive
EpiCept Corporation today announced that the Israeli Ministry of Health has approved the marketing application for CepleneĀ®, indicated for remission maintenance and prevention of relapse in adult patients with Acute Myeloid Leukemia (AML) in first remission. Megapharm Ltd. is EpiCept's partner in Israel and upon Ministry of Health approval of labeling and other technical matters the company is expected to launch CepleneĀ® in the first quarter of 2011.
In this PLoS "Speaking of Medicine" blog post, Julien Potet and Katy Athersuch of Medecins Sans Frontieres' (MSF) Access Campaign say that the WHO's decision last week to "simply continue monitoring" the medical research and development (R&D) industry's ability to address the needs of people living in developing countries "by creating a global R&D 'observatory'" is "a deeply disappointing outcome that will not help re-shape priorities, increase funding or catalyze development of urgently needed new medical tools; at best it will only underscore further how badly these actions are needed."
Although low-income Asian Americans are at a high risk for diabetes, hypertension, heart attack and stroke, they are under a misconception that their diet is healthy and not a risk factor for these chronic diseases.
President Obama's support for his signature health care act took a fresh hit Friday. The Catholic Health Association, the nation's largest private health care provider, has rebuffed the latest White House moves to make its contraception coverage mandate more acceptable to Catholics and conservative evangelicals, according to Religion News Service.
In late 2013 the Caribbean had its first case of the mosquito-borne chikungunya virus. Today there have been almost 1.2 million cases in 44 countries or territories, including 177 cases in 31 U.S. States. Vanderbilt University Medical Center's James Crowe, M.D., Ann Scott Carell Professor and director of the Vanderbilt Vaccine Center, and his team are reporting the first large panel of antibody treatments against this disease in the current issue of Cell Host and Microbe.
› Verified 9 days ago